top of page

New opportunities in bladder treatments.

Writer's picture: Gabriel KornGabriel Korn

As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration providing a better understanding of the future of direct (non-oral) treatments for bladder and Urinary Tract Infections (UTI). What does this mean?

  • From a clinical perspective this is a shift in quality of life for the patient and substantially better safety and efficacy.

  • From a marketing perspective this form of treatment opens many new opportunities in bladder treatments.

Download the PDF article here:



32 views0 comments

Recent Posts

See All

Aiming at the right urological targets

Last week, Professor of urology, Chris Chapple had a review published in  Continence , titled “The sensory system is a target for...

Anachronistic Bladder Treatments

During much of my medical career, my understanding of the human bladder was that it was a reservoir for the body’s metabolic waste and...

Drugs and dementia

Colleagues While I applaud last week’s publication of the Lancet Commission report on Dementia 2024 that provided updated information on...

Comments


Contact Us

Tel: +44 (0) 1603 626 960

Email: info@uropharma.com

©2017-2021 UroPharma, Inc. All Rights Reserved

3.png
2.png

Social Media

  • LinkedIn Social Icon

Linkedin.com/company/uropharma

  • Twitter

Twitter.com/UroPharma

  • Facebook

Facebook.com/bladdercontrol

4_edited_edited.jpg
image.png
bottom of page